Document is current
Any future updates will be listed below
-
Authors
Xiong, Zujian
Dodson, Brittany P.
Rogers, Matthew B.
Sneiderman, Chaim T.
Janesko-Feldman, Keri
Vagni, Vincent
Manole, Mioara
Li, Xuejun
Rajasundaram, Dhivyaa
Clark, Robert S. B.
Raphael, Itay
Morowitz, Michael J.
Mariño, Eliana
Kochanek, Patrick M.
Jha, Ruchira M.
Kohanbash, Gary https://orcid.org/0000-0002-3953-8022
Simon, Dennis W. https://orcid.org/0000-0002-3824-2326
-
Funding
Funding for this research was provided by:
National Institutes of Neurological Disorders and Stroke (R21 NS131689)
National Institutes of Neurological Disorders and Stroke (R21 NS131689)
UPMC Children's Hospital of Pittsburgh
National Institutes of Health (R01NS 127372)
- License Information
-
More Information
Article History
Received: 25 August 2025
Accepted: 27 October 2025
First Online: 9 December 2025
Declarations
:
: Not applicable.
: Not applicable.
: Eliana Mariño is an inventor on a patent WO2018027274A1 submitted by Monash University that covers methods and compositions of metabolites for treatment and prevention of autoimmune disease related to this paper and stock ownership for ImmunoBiota Therapeutics Pty Ltd. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, the present work. Other authors declare no competing interests.
